Bernie Zeiher

Trained as a pulmonary and critical care physician, he has led the development of products in critical care, pain, immunology, and infectious diseases. He was involved in and oversaw the approval of over 15 products. He is passionate about addressing unmet patients’ needs in underserved and severe diseases. Dr. Zeiher has held increasing leadership and executive responsibility positions at Astellas, Pfizer and Lilly, including board memberships, CMO and President of Development.

Dr. Zeiher received his Doctor of Medicine from Case Western Reserve University School of Medicine and a Bachelor of Science in Biology from the University of Toledo.

Suggested For You

perspectives

April 24th, 2025

How to Derisk Clinical Development with Unified Trial Design and Regulatory Strategy

perspectives

April 8th, 2025

Updated UK Clinical Trial Regulation: The Key Changes and Impact on Development Safety Update Report (DSUR) Requirements

news

April 3rd, 2025

Datacise by MMS Wins 2025 Data Breakthrough Award for Best Data Science Solution